Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonists.
Clitherow
J W
JW
Department of Medicinal Chemistry, Glaxo Research and Development Ltd., Ware, Hertfordshire, England.
Scopes
D I
DI
Skingle
M
M
Jordan
C C
CC
Feniuk
W
W
Campbell
I B
IB
Carter
M C
MC
Collington
E W
EW
Connor
H E
HE
Higgins
G A
GA
D000813:Anilides / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D002490:Central Nervous System / Q000378:metabolism; D004285:Dogs; D006168:Guinea Pigs; D012702:Serotonin Antagonists
D000813:Anilides; D012702:Serotonin Antagonists; C034595:benzanilide